S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Endo InternationalZEALAND PHARMA/SCannTrustCytokineticsKura Oncology
SymbolNASDAQ:ENDPNASDAQ:ZEALN/ANASDAQ:CYTKNASDAQ:KURA
Price Information
Current Price$4.80$27.19N/A$11.38$14.95
52 Week RangeHoldBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$7.58$34.33N/A$20.17$27.25
% Upside from Price Target57.98% upside26.27% upsideN/A77.21% upside82.27% upside
Trade Information
Market Cap$760.68 million$860.72 million$771.17 million$667.77 million$674.23 million
Beta1.332.054.521.552.58
Average Volume5,333,0689,736N/A493,572265,329
Sales & Book Value
Annual Revenue$2.95 billion$6.02 million$15.96 million$31.50 millionN/A
Price / Sales0.37143.720.0021.20N/A
Cashflow$8.88 per share$3.54 per shareN/AN/AN/A
Price / Cash0.547.68N/AN/AN/A
Book Value($2.22) per share$5.49 per shareN/A$0.47 per share$4.22 per share
Price / Book-2.164.95NaN24.21N/A
Profitability
Net Income$-1,031,470,000.00$92.07 millionN/A$-106,290,000.00$-60,450,000.00
EPS$2.89$3.00$0.07($1.95)($1.72)
Trailing P/E Ratio1.669.0632.43N/AN/A
Forward P/E Ratio2.05N/A0.00N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-19.98%N/AN/A-308.73%N/A
Return on Equity (ROE)-129.30%50.63%N/A-575.21%-32.79%
Return on Assets (ROA)5.75%41.41%N/A-52.47%-29.65%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A12.35%0.03%
Current Ratio1.50%4.48%N/A8.42%23.50%
Quick Ratio1.32%4.48%N/A8.42%23.50%
Ownership Information
Institutional Ownership Percentage95.78%9.07%0.08%76.17%85.47%
Insider Ownership Percentage1.50%N/AN/A5.70%11.00%
Miscellaneous
Employees2,910149N/A13043
Shares Outstanding226.39 million31.82 million105.64 million58.68 million45.22 million
Next Earnings Date11/5/2019 (Confirmed)11/21/2019 (Estimated)N/A11/7/2019 (Estimated)11/4/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableOptionable
 Endo InternationalZEALAND PHARMA/SCannTrustCytokineticsKura Oncology

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel